Karyopharm Therapeutics Inc Revenue per Employee (KPTI), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Karyopharm Therapeutics Inc   (NASDAQ: KPTI)
 

Karyopharm Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Karyopharm Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 643,075, but the productivity of Karyopharm Therapeutics Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 131 other companies have achieved higher revenue per employee. While Karyopharm Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 1121 to 1262. Karyopharm Therapeutics Inc has 228 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KPTI Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -11.86 % 16.83 % 11.58 % 13.57 % -11.35 %
Sales per Employee (TTM) $ 643,075 662,798 640,645 625,132 602,057
KPTI's Total Ranking # 1262 # 1121 # 788 # 519 # 1542
Seq. Revenue Change -4.66 % 2.9 % -22.63 % 16.12 % 26.37 %

KPTI Company Profile >> Back to KPTI Efficiency Comparisons >> Compare KPTI Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 86
Healthcare Sector # 132
Overall Market # 1262

Revenue per Employee Statistics
High Average Low
$ 1,102,224 $ 511,693 $ 728
(Jun 30 2022)   (Jun 30 2017)



Financial Statements
Karyopharm Therapeutics Inc 's Revenue MRQ $ 33 Millions Visit KPTI's Income Statement
Karyopharm Therapeutics Inc 's Revenues TTM $ 147 Millions Visit KPTI's aggregate revenue growth
What are KPTI's Sales? Visit KPTI's Sales by Segment




Other Ratios
Karyopharm Therapeutics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
KPTI's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for KPTI's Competitors
Revenue per Employee for KPTI's Suppliers
Revenue per Employee for KPTI's Customers

You may also want to know
KPTI's Sales Growth Rates KPTI's Pe Price to earnings ratio KPTI's Receivables Turnover Ratio KPTI's Stock Quote
KPTI's Net Income Growth Rates KPTI's Ps Price to Sales ratio KPTI's Sales per Employee KPTI's Asset Turnover Ratio
KPTI's Net Margin KPTI's Pb Price to Book ratio KPTI's Financial Strength Ratios KPTI's Dividend Payout Ratio
Date modified: 2026-09-26T07:08:33+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Siga Technologies Inc  1,095,079.92 $ 53.659  Million 49 
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ptc Therapeutics inc   1,017,915.24 $ 1,008.754  Million 991 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Regeneron Pharmaceuticals Inc   1,008,092.15 $ 15,534.700  Million 15,410 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million 8 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Evolus Inc   949,440.12 $ 317.113  Million 334 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
Ardelyx inc   922,073.62 $ 450.894  Million 489 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Carlisle Companies Incorporated  863,898.31 $ 5,097.000  Million 5,900 
Verastem Inc   858,098.04 $ 87.526  Million 102 
Emergent Biosolutions Inc   855,777.78 $ 770.200  Million 900 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 
Vir Biotechnology Inc   826,231.61 $ 303.227  Million 367 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.